Catheter Precision Inc (VTAK)

$0.33

-0.01

(-2.06%)

Market is closed - opens 7 PM, 09 Oct 2024

Performance

  • $0.31
    $0.33
    $0.33
    downward going graph

    5.39%

    Downside

    Day's Volatility :6.47%

    Upside

    1.14%

    downward going graph
  • $0.31
    $8.40
    $0.33
    downward going graph

    5.39%

    Downside

    52 Weeks Volatility :96.28%

    Upside

    96.07%

    downward going graph

Returns

PeriodCatheter Precision IncIndex (Russel 2000)
3 Months
-91.21%
0.0%
6 Months
-93.62%
0.0%
1 Year
-92.35%
0.0%
3 Years
-93.96%
-20.8%

Highlights

Market Capitalization
921.4K
Book Value
$18.9
Earnings Per Share (EPS)
30.61
PE Ratio
0.01
Wall Street Target Price
41.0
Profit Margin
0.0%
Operating Margin TTM
-2921.51%
Return On Assets TTM
-21.56%
Return On Equity TTM
-49.81%
Revenue TTM
436.0K
Revenue Per Share TTM
0.6
Quarterly Revenue Growth YOY
-3.1%
Gross Profit TTM
0.0
EBITDA
-8.6M
Diluted Eps TTM
30.61
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
-2.63
EPS Estimate Next Quarter
-1.8

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Catheter Precision Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 12324.24%

Current $0.33
Target $41.00

Technicals Summary

Sell

Neutral

Buy

Catheter Precision Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Catheter Precision Inc
Catheter Precision Inc
-20.74%
-93.62%
-92.35%
-93.96%
-93.96%
Stryker Corporation
Stryker Corporation
-4.86%
-0.03%
31.48%
35.58%
66.35%
Boston Scientific Corp.
Boston Scientific Corp.
3.86%
22.94%
63.82%
100.31%
122.33%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
4.31%
-26.34%
-5.98%
-36.82%
-8.54%
Abbott Laboratories
Abbott Laboratories
-1.55%
1.95%
18.47%
-1.93%
44.19%
Medtronic Plc
Medtronic Plc
-2.74%
3.87%
17.32%
-29.55%
-17.43%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Catheter Precision Inc
Catheter Precision Inc
0.01
0.01
NA
0.0
-0.5
-0.22
NA
18.9
Stryker Corporation
Stryker Corporation
39.06
38.48
2.54
12.01
0.19
0.07
0.01
51.86
Boston Scientific Corp.
Boston Scientific Corp.
68.63
68.63
2.08
2.41
0.09
0.05
NA
13.85
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
25.41
25.41
3.46
2.62
0.22
0.12
NA
12.35
Abbott Laboratories
Abbott Laboratories
35.76
35.76
4.11
4.66
0.14
0.06
0.02
22.6
Medtronic Plc
Medtronic Plc
30.31
30.31
1.67
5.2
0.08
0.04
0.03
37.39
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Catheter Precision Inc
Catheter Precision Inc
Buy
$1.0M
-93.96%
0.01
0.0%
Stryker Corporation
Stryker Corporation
Buy
$133.7B
66.35%
39.06
16.12%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$124.3B
122.33%
68.63
12.0%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$38.9B
-8.54%
25.41
23.74%
Abbott Laboratories
Abbott Laboratories
Buy
$197.2B
44.19%
35.76
13.65%
Medtronic Plc
Medtronic Plc
Buy
$115.5B
-17.43%
30.31
12.06%

Insights on Catheter Precision Inc

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 63.8% return, outperforming this stock by 156.1%

Company Information

advanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. we currently manufacture and market two lines of products: dabra catheter and laser is cleared by the u.s. fda as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (pad), which commonly occurs in the legs. pharos excimer laser pharos is designed for use in the treatment of inflammatory skin conditions and is fda cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of

Organization
Catheter Precision Inc
Employees
14
CEO
Mr. David A. Jenkins
Industry
Miscellaneous

FAQs